Jacobson Pharma Corp. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG677291067
HKD
1.25
0.02 (1.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,576.90
1,467.80
1,267.60
1,595.54
1,445.91
1,571.46
1,478.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,576.90
1,467.80
1,267.60
1,595.54
1,445.91
1,571.46
1,478.12
Raw Material Cost
883.96
847.32
728.68
975.02
911.77
901.70
823.42
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
473.05
452.06
382.29
424.02
403.35
454.46
418.18
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
41.37
78.71
61.41
25.69
30.14
55.36
66.20
Selling and Distribution Expenses
322.00
325.93
296.76
390.99
346.86
370.59
318.64
Other Expenses
-51.22
-52.43
-44.25
-44.31
-43.17
-50.61
-48.18
Total Expenditure (Excl Depreciation)
1,208.19
1,179.70
1,026.60
1,372.65
1,260.41
1,276.02
1,144.60
Operating Profit (PBDIT) excl Other Income
368.7
288.09999999999997
241
222.89999999999998
185.5
295.4
333.5
Other Income
77.63
52.46
43.09
28.90
19.86
20.67
13.69
Operating Profit (PBDIT)
590.20
482.38
432.74
444.39
397.07
482.37
462.94
Interest
41.37
78.71
61.41
25.69
30.14
55.36
66.20
Exceptional Items
-31.73
-7.43
29.30
9.10
50.87
2.11
23.37
Gross Profit (PBDT)
692.94
620.48
538.92
620.52
534.15
669.76
654.70
Depreciation
143.87
141.82
148.65
192.60
191.70
166.27
115.73
Profit Before Tax
373.23
254.42
251.97
235.20
226.10
262.86
304.39
Tax
72.79
44.41
42.98
43.73
34.26
46.02
55.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
300.83
210.24
207.51
177.67
173.71
214.49
246.79
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
300.83
210.24
207.51
177.67
173.71
214.49
246.79
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.07
-0.14
10.04
12.60
2.97
6.78
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
300.83
210.17
207.37
187.71
186.31
217.46
253.58
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
2,453.22
2,372.14
2,736.69
2,491.32
2,389.85
2,537.74
2,647.17
Earnings per share (EPS)
0.15
0.12
0.13
0.09
0.09
0.11
0.13
Diluted Earnings per share
0.15
0.12
0.13
0.09
0.09
0.11
0.13
Operating Profit Margin (Excl OI)
23.38%
19.63%
19.01%
13.97%
12.83%
18.8%
22.56%
Gross Profit Margin
32.79%
27.0%
31.61%
26.81%
28.89%
27.31%
28.42%
PAT Margin
19.08%
14.32%
16.37%
11.14%
12.01%
13.65%
16.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 7.43% vs 15.79% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 43.10% vs 1.35% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 19.24% vs 10.34% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -47.40% vs 28.18% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Jacobson Pharma Corp. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
1,576.90
782.29
794.61
101.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,576.90
782.29
794.61
101.57%
Raw Material Cost
883.96
368.58
515.38
139.83%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
473.05
99.46
373.59
375.62%
Power Cost
0
0
0.00
Manufacturing Expenses
41.37
4.46
36.91
827.58%
Selling and Distribution Expenses
322.00
185.74
136.26
73.36%
Other Expenses
-51.22
-10.39
-40.83
-392.97%
Total Expenditure (Excl Depreciation)
1,208.19
554.33
653.86
117.96%
Operating Profit (PBDIT) excl Other Income
368.70
227.97
140.73
61.73%
Other Income
77.63
18.10
59.53
328.90%
Operating Profit (PBDIT)
590.20
298.35
291.85
97.82%
Interest
41.37
4.46
36.91
827.58%
Exceptional Items
-31.73
0.00
-31.73
Gross Profit (PBDT)
692.94
413.71
279.23
67.49%
Depreciation
143.87
52.28
91.59
175.19%
Profit Before Tax
373.23
241.60
131.63
54.48%
Tax
72.79
38.98
33.81
86.74%
Provisions and contingencies
0
0
0.00
Profit After Tax
300.83
197.26
103.57
52.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
300.83
197.26
103.57
52.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
5.43
-5.43
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
300.83
202.69
98.14
48.42%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
2,453.22
1,082.02
1,371.20
126.73%
Earnings per share (EPS)
0.15
0.24
-0.09
-37.50%
Diluted Earnings per share
0.15
0.24
-0.09
-37.50%
Operating Profit Margin (Excl OI)
23.38%
29.14%
0.00
-5.76%
Gross Profit Margin
32.79%
37.57%
0.00
-4.78%
PAT Margin
19.08%
25.22%
0.00
-6.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 157.69 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 7.43% vs 15.79% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 30.08 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 43.10% vs 1.35% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.26 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 19.24% vs 10.34% in Mar 2024

Annual - Interest
Interest 4.14 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -47.40% vs 28.18% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.38%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024